Iowa Neurological Association Annual Meeting

Iowa City, IA US
October 5, 2024

Registration


Cost

  • INA Member: $50
  • Non-INA Member: $200
  • Advanced Practice Providers and Nurses: $25
  • Students and Residents: $0

Learn more and register.

If you have questions, please email Grace Fleming.
 

Purpose

Increase learners' knowledge of trends in multiple disease factors and delivery methods to improve quality of care provided in relation to neurology. 

Agenda

TimePresentation Title and Speaker
7:30 amRegistration
8:30 am

Epilepsy
Mark Granner, MD, Neurologist, University of Iowa Hospitals and Clinics

  1. Identify the prevalence and costs of drug-refractory epilepsy and the limitations of traditional therapies.
  2. Recognize the role of recent advances in device and surgical therapy.
  3. Anticipate novel therapies in the investigational pipeline.
9:30 amBreak
9:45 am

Kinetic Movement Disorders Presentation with a Feature on Huntington's Disease 
Annie Killoran, MD, MSc, University of Iowa Hospitals and Clinics – Huntington's Disease Center of Excellence

  1. Recognize distinguishing clinical features of different choreiform movement disorders.
  2. Decide on appropriate testing for various scenarios.
  3. Devise suitable management plans.

 

 

Chronic Daily Headache: Considering Non-Migraine Diagnoses
Alicia L. Duyvejonck, DNP, AGNP, NP-C, AQH, Genesis Headache Clinic 

  1. Discuss the prevalence and demographic characteristics of chronic daily headaches.
  2. Formulate a differential diagnosis for chronic daily headaches, considering primary and secondary causes.
  3. Utilize appropriate diagnostic tools and imaging studies to identify secondary causes of chronic daily headaches.
  4. Outline appropriate treatment options for chronic headaches, including pharmacological and nonpharmacological interventions.
10:45 amBreak
11:00 am

Neurologic Autonomic Disorders and Testing
Kamal Shouman, MD, Mayo Clinic

  1. Recognize the major neurologic autonomic disorders and their presentation.
  2. Identify relevant neurologic autonomic tests and their role in patient care.
  3. Describe diagnostic approaches to neurologic autonomic conditions.

 

 

Cross-Sectional Neuroanatomy and Neuroimaging
Justin Sipla, PhD, University of Iowa Hospitals and Clinics

  1. Identify the ventricles and subarachnoid cisterns and relate these to common pathological features.
  2. Identify major brain areas, including deep forebrain structures like the basal ganglia, internal capsule, and thalamus, and relate these to common pathological features.
  3. Review the vascular supply of each area identified and relate these to common stroke patterns.
12:00 pmLunch
1:15 pm

Clinical Update for Individualized Treatment Plans for Patients with Generalized Myasthenia Gravis 
James F. Howard, MD, FAAN, University of North Carolina School of Medicine

  1. Review the disease symptom heterogeneity of generalized myasthenia gravis and the rationale for individualized therapy to optimize outcomes through periods of waxing and waning symptom burden.
  2. Analyze clinical trial data, including real-world data for the clinical applications of FcRn and complement inhibitors in managing gMG.
  3. Discuss the effects of individual patient and disease specifics on gMG treatment planning, dosing recommendations, and the management of symptom-free periods.
  4. Review the impact of comorbidities on treatment goals and outcomes for patients with gMG.
2:15 pmBreak
2:30 pm

Meningovascular Syphilis: An Under-Recognized Cause of Stroke in the Young
Rachel Marshall, MD, University of Iowa Carver College of Medicine, PGY-3

  1. Review the most common presentations of neurosyphilis and the high morbidity associated with this diagnosis.
  2. Develop a comprehensive differential diagnosis of stroke in the young, particularly in high-risk populations. 
  3. Review workup and diagnosis of a classically challenging and under-recognized stroke entity.
3:00 pmAdjourn
Course summary
Available credit: 
  • 4.50 AMA PRA Category 1 Credits™
  • 4.50 AOA Category 2­A
  • 4.50 CE Contact Hour(s)
  • 4.50 IBON
Course opens: 
10/05/2024
Course expires: 
10/05/2024
Event starts: 
10/05/2024 - 8:30am CDT
Event ends: 
10/05/2024 - 3:00pm CDT
Cost:
$200.00
Add to calendar: 
Rating: 
0
Graduate Iowa City
210 S. Dubuque St.
Iowa City, IA 52240
United States

Accreditation Statements

  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University Medicine and Health Sciences (DMU) and the Iowa Neurological Association. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 4.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • Nurse: Des Moines University Medicine and Health Sciences is Iowa Board of Nursing approved provider #112. This activity has been reviewed and approved for 4.5 continuing education contact hour(s). Nurses must attend the entire session to receive credit. Partial session credit is prohibited and will be forfeited.
  • Other Health Professionals: This activity is designated for 4.5 AMA PRA Category 1 Credit(s)TM. 

Educational Grants

No ineligible company provided financial support for this continuing education activity.

Disclosures

The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers. 

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

  • Todd Ajax, MD - Planning Committee Member
  • Grace Fleming - Activity Director
  • Mark Granner, MD - Speaker
  • Christopher Groth, MD - Planning Committee Member
  • Rahul Khanna, MD - Planning Committee Member
  • Shivakrishna Kovi, MD - Planning Committee Member
  • Rachel Marshall, MD - Speaker
  • Nicole McMenamin, CHCP - Activity Coordinator and Planning Committee Member
  • Justin Sipla, PhD - Speaker
  • Nicholas Wasko, MD, PhD - Planning Committee Member
  • John Wright, MD - Planning Committee Member

Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated.

  • Alicia L. Duyvejonck, DNP, AGNP, NP-C, AQH - Speaker
    • Advisory Board: Lilly, Tonix
    • Honoraria: Lilly, Impel, Lundbeck, AbbVie, Tonix
    • Speaker’s Bureau: Lilly, Abbvie, Lundbeck, Impel, Tonix
    • The financial relationships are not relevant to the content of the educational activity.
  • Christine Gill, MD - Planning Committee Member
    • Advisory Board: TG Therapeutics
    • The financial relationship is not relevant to the content of the educational activity.
  • James F. Howard, MD, FAAN - Speaker
  • Annie Killoran, MD, MSc - Speaker
    • She does not have a financial relationship with an ineligible company; however, she intends to discuss the off-label use of a commercial product or device and agrees to inform the learners.
  • Kamal Shouman, MD - Speaker
    • He does not have a financial relationship with an ineligible company; however, he intends to discuss the off-label use of a commercial product or device and agrees to inform the learners.

Disclaimer

The information provided in this activity is for continuing education. It is not meant to substitute for the independent medical judgment of a healthcare provider regarding the diagnostic and treatment options for a specific patient’s medical condition.

Available Credit

  • 4.50 AMA PRA Category 1 Credits™
  • 4.50 AOA Category 2­A
  • 4.50 CE Contact Hour(s)
  • 4.50 IBON

Price

Cost:
$200.00
Please login or Create an Account to take this course.

Cost

  • INA Member: $50
  • Non-INA Member: $200
  • Advanced Practice Providers and Nurses: $25
  • Students and Residents: $0

Learn more and register.

If you have questions, please email Grace Fleming.